FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services home page

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

horizontal rule

figures

Figure 1

This figure shows a flow chart describing the process used to determine how many protocols met the guidance for listing in ClinicalTrials.gov. It uses oncology studies as an example. The chart consists of descriptive text connected by downward pointing arrows showing the next step in making the determination.

The text reads as follows, with downward arrows pointing to each subsequent body of text:

122 cancer protocols submitted.

122 protocols for serious or life-threatening disases and conditions.

50 phase 2, 3, or 4 protocols.

45 protocols with primary or secondary efficacy endpoints.

Follow up with sponsors. (Shown as an action with the downward arrow)

34 phase 2, 3, or 4 protocols with primary or secondary efficacy endpoints required to be listed in ClinicalTrials.gov

26 trials listed in ClinicalTrials.gov (compliance rate = 76%)

horizontal rule

back to report

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility

FDA Office of Special Health Issues